Quaker Chemical (NYSE:KWR) Earns “Neutral” Rating from Piper Sandler

Quaker Chemical (NYSE:KWR)‘s stock had its “neutral” rating reaffirmed by research analysts at Piper Sandler in a research note issued to investors on Tuesday, MarketBeat reports. They currently have a $170.00 price target on the specialty chemicals company’s stock, down from their previous price target of $200.00. Piper Sandler’s price objective would indicate a potential upside of 30.02% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the stock. StockNews.com raised shares of Quaker Chemical from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Quaker Chemical from $190.00 to $182.00 and set a “buy” rating for the company in a report on Monday, November 4th. Finally, Royal Bank of Canada lowered their price objective on shares of Quaker Chemical from $195.00 to $180.00 and set an “outperform” rating for the company in a research report on Monday, November 4th.

Quaker Chemical Stock Performance

NYSE KWR opened at $130.75 on Tuesday. Quaker Chemical has a 12-month low of $128.31 and a 12-month high of $207.83. The firm has a 50-day moving average price of $153.93 and a two-hundred day moving average price of $162.31. The company has a market capitalization of $2.33 billion, a P/E ratio of 19.17, a P/E/G ratio of 1.84 and a beta of 1.39. The company has a quick ratio of 1.88, a current ratio of 2.54 and a debt-to-equity ratio of 0.48.

Quaker Chemical (NYSE:KWR) last issued its quarterly earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.08 by ($0.19). The company had revenue of $462.27 million for the quarter, compared to analyst estimates of $469.17 million. Quaker Chemical had a return on equity of 10.10% and a net margin of 6.58%. The company’s quarterly revenue was down 5.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.05 EPS. Analysts anticipate that Quaker Chemical will post 7.78 earnings per share for the current year.

Insider Buying and Selling at Quaker Chemical

In related news, SVP David Slinkman sold 1,700 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $167.80, for a total transaction of $285,260.00. Following the sale, the senior vice president now owns 2,825 shares in the company, valued at $474,035. The trade was a 37.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Jeewat Bijlani sold 645 shares of the company’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $165.98, for a total value of $107,057.10. Following the completion of the transaction, the executive vice president now directly owns 4,747 shares of the company’s stock, valued at approximately $787,907.06. The trade was a 11.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Quaker Chemical

Hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its holdings in shares of Quaker Chemical by 105.3% during the third quarter. GAMMA Investing LLC now owns 156 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 80 shares during the period. KBC Group NV lifted its holdings in Quaker Chemical by 50.9% during the 3rd quarter. KBC Group NV now owns 525 shares of the specialty chemicals company’s stock worth $88,000 after buying an additional 177 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its position in shares of Quaker Chemical by 100.0% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 906 shares of the specialty chemicals company’s stock valued at $153,000 after buying an additional 453 shares during the last quarter. iSAM Funds UK Ltd acquired a new stake in shares of Quaker Chemical in the third quarter valued at about $208,000. Finally, Edgestream Partners L.P. bought a new position in shares of Quaker Chemical during the third quarter worth about $215,000. 77.46% of the stock is currently owned by institutional investors and hedge funds.

About Quaker Chemical

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.